SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-23-122233
Filing Date
2023-04-27
Accepted
2023-04-27 16:19:54
Documents
7

Document Format Files

Seq Description Document Type Size
1 DEFA14A d823041ddefa14a.htm DEFA14A 31750
2 GRAPHIC g823041s0001a.jpg GRAPHIC 2044
3 GRAPHIC g823041s0001b.jpg GRAPHIC 20396
4 GRAPHIC g823041s0001c.jpg GRAPHIC 19279
5 GRAPHIC g823041sp001d.jpg GRAPHIC 1967
6 GRAPHIC g823041sp001e.jpg GRAPHIC 2330
7 GRAPHIC g823041spp2a.jpg GRAPHIC 821
  Complete submission text file 0001193125-23-122233.txt   98170
Mailing Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 131 OYSTER POINT BOULEVARD SUITE 300 SOUTH SAN FRANCISCO CA 94080 650-443-7400
Harpoon Therapeutics, Inc. (Filer) CIK: 0001708493 (see all company filings)

IRS No.: 473458693 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38800 | Film No.: 23857275
SIC: 2836 Biological Products, (No Diagnostic Substances)